NCT03560856 A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT03558490 A Study to Assess the Feasibility of an E-Health System (ZEMY) Designed to Manage Symptoms in Participants With Breast Cancer Under Anti-Cancer Treatment Status COMPLETED Phase PHASE2
NCT03557554 Investigating the Preventative Ability of Massage Therapy on Paclitaxel Induced Peripheral Neuropathy Status TERMINATED Phase NA
NCT03556813 Artificial Intelligence vs Physicians for Breast Cancer Patients' Information Status COMPLETED Phase N/A
NCT03556397 Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy Status COMPLETED Phase NA
NCT03556358 Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer Status COMPLETED Phase PHASE3
NCT03554434 An Expanded Access Program for AM0010 (Pegilodecakin) Status NO_LONGER_AVAILABLE Phase N/A
NCT03552718 QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. Status COMPLETED Phase PHASE1
NCT03546686 Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03546478 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization Status COMPLETED Phase EARLY_PHASE1
NCT03544762 Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Status UNKNOWN Phase PHASE3
NCT03543072 A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients Status UNKNOWN Phase N/A
NCT03543059 A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients Status UNKNOWN Phase N/A
NCT03542175 A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy Status COMPLETED Phase PHASE1
NCT03541863 Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients Status COMPLETED Phase N/A